Literature DB >> 28017398

Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach.

Shoko Vos1, Johannes J M van Delden2, Paul J van Diest3, Annelien L Bredenoord2.   

Abstract

Advances in genome sequencing together with the introduction of personalized medicine offer promising new avenues for research and precision treatment, particularly in the field of oncology. At the same time, the convergence of genomics, bioinformatics, and the collection of human tissues and patient data creates novel moral duties for researchers. After all, unprecedented amounts of potentially sensitive information are being generated. Over time, traditional research ethics principles aimed at protecting individual participants have become supplemented with social obligations related to the interests of society and the research enterprise at large, illustrating that genomic medicine is also a social endeavor. In this review we provide a comprehensive assembly of moral duties that have been attributed to genomics researchers and offer suggestions for responsible advancement of personalized genomic cancer care.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; ethics; genomics; moral duties; next-generation sequencing; personalized medicine.

Mesh:

Year:  2016        PMID: 28017398     DOI: 10.1016/j.tig.2016.11.006

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  8 in total

1.  Whole-exome sequencing in intellectual disability; cost before and after a diagnosis.

Authors:  Terry Vrijenhoek; Eline M Middelburg; Glen R Monroe; Koen L I van Gassen; Joost W Geenen; Anke M Hövels; Nine V Knoers; Hans Kristian Ploos van Amstel; Gerardus W J Frederix
Journal:  Eur J Hum Genet       Date:  2018-06-29       Impact factor: 4.246

2.  Community Partnership in Precision Medicine: Themes from a Community Engagement Conference.

Authors:  Loretta Jones; Kenneth Wells; Henry J Lin; Christina Wang; Audrey Kawaiopua Alo; Pluscedia Williams; Felica Jones; Patricia I Dickson; Sophia Han; Dominga Pardo; Keith Norris; Andrea Jones; Aziza Wright; Kawen Young; Jerome I Rotter
Journal:  Ethn Dis       Date:  2018-09-06       Impact factor: 1.847

3.  Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study.

Authors:  Marlies Saelaert; Heidi Mertes; Tania Moerenhout; Elfride De Baere; Ignaas Devisch
Journal:  BMC Med Ethics       Date:  2020-01-30       Impact factor: 2.652

4.  From Genetics to Genomics: Facing the Liability Implications in Clinical Care.

Authors:  Gary Marchant; Mark Barnes; James P Evans; Bonnie LeRoy; Susan M Wolf
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

5.  Researchers' perspectives on return of individual genetics results to research participants: a qualitative study.

Authors:  Erisa Sabakaki Mwaka; Deborah Ekusai Sebatta; Joseph Ochieng; Ian Guyton Munabi; Godfrey Bagenda; Deborah Ainembabazi; David Kaawa-Mafigiri
Journal:  Glob Bioeth       Date:  2021-03-09

6.  Better governance starts with better words: why responsible human tissue research demands a change of language.

Authors:  Michael A Lensink; Karin R Jongsma; Sarah N Boers; Annelien L Bredenoord
Journal:  BMC Med Ethics       Date:  2022-09-01       Impact factor: 2.834

Review 7.  Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe.

Authors:  Justo Pinzón-Espinosa; Marte van der Horst; Janneke Zinkstok; Jehannine Austin; Cora Aalfs; Albert Batalla; Patrick Sullivan; Jacob Vorstman; Jurjen J Luykx
Journal:  Transl Psychiatry       Date:  2022-10-11       Impact factor: 7.989

8.  Decentralized genomics audit logging via permissioned blockchain ledgering.

Authors:  Nicholas D Pattengale; Corey M Hudson
Journal:  BMC Med Genomics       Date:  2020-07-21       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.